BR112022020991A2 - BIODEGRADABLE POLYMER DISPERSION, COMPOSITION COMPRISING THE SAME AND SKIN ENHANCEMENT SYSTEM - Google Patents
BIODEGRADABLE POLYMER DISPERSION, COMPOSITION COMPRISING THE SAME AND SKIN ENHANCEMENT SYSTEMInfo
- Publication number
- BR112022020991A2 BR112022020991A2 BR112022020991A BR112022020991A BR112022020991A2 BR 112022020991 A2 BR112022020991 A2 BR 112022020991A2 BR 112022020991 A BR112022020991 A BR 112022020991A BR 112022020991 A BR112022020991 A BR 112022020991A BR 112022020991 A2 BR112022020991 A2 BR 112022020991A2
- Authority
- BR
- Brazil
- Prior art keywords
- polymer dispersion
- biodegradable polymer
- composition
- same
- enhancement system
- Prior art date
Links
- 229920002988 biodegradable polymer Polymers 0.000 title abstract 5
- 239000004621 biodegradable polymer Substances 0.000 title abstract 5
- 239000006185 dispersion Substances 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 6
- 235000014655 lactic acid Nutrition 0.000 abstract 3
- 239000004310 lactic acid Substances 0.000 abstract 3
- 229920000642 polymer Polymers 0.000 abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229920001400 block copolymer Polymers 0.000 abstract 1
- 239000004815 dispersion polymer Substances 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 229920001553 poly(ethylene glycol)-block-polylactide methyl ether Polymers 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/025—Explicitly spheroidal or spherical shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/90—Block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/654—The particulate/core comprising macromolecular material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
DISPERSÃO DE POLÍMERO BIODEGRADÁVEL, COMPOSIÇÃO COMPREENDENDO A MESMA E SISTEMA DE MELHORIA DA PELE. A presente revelação refere-se a uma dispersão de polímero biodegradável contendo um polímero à base de ácido láctico, um copolímero de blocos contendo polietilenoglicol e polímero à base de ácido láctico (PEG-PLA), e uma mistura de ácido hialurônico, em que a dispersão de polímero biodegradável tem excelente atividade por si só, tem excelente estabilidade de dispersão do polímero à base de ácido láctico, e é capaz de efetivamente suportar os ingredientes ativos. Além disso, a presente revelação refere-se a uma composição contendo a dispersão de polímero biodegradável e um sistema de melhoria da pele.BIODEGRADABLE POLYMER DISPERSION, COMPOSITION COMPRISING THE SAME AND SKIN ENHANCEMENT SYSTEM. The present disclosure relates to a biodegradable polymer dispersion containing a lactic acid-based polymer, a block copolymer containing polyethylene glycol and lactic acid-based polymer (PEG-PLA), and a blend of hyaluronic acid, wherein the Biodegradable polymer dispersion has excellent activity by itself, has excellent stability of lactic acid-based polymer dispersion, and is able to effectively support the active ingredients. Furthermore, the present disclosure relates to a composition containing the biodegradable polymer dispersion and a skin improvement system.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200110235 | 2020-08-31 | ||
KR1020210112934A KR20220029449A (en) | 2020-08-31 | 2021-08-26 | Biodegradable polymer dispersion, composition comprising same, and skin improvement system |
PCT/KR2021/011507 WO2022045823A1 (en) | 2020-08-31 | 2021-08-27 | Biodegradable polymer dispersion, composition comprising same, and skin improvement system |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022020991A2 true BR112022020991A2 (en) | 2023-03-07 |
Family
ID=80355507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022020991A BR112022020991A2 (en) | 2020-08-31 | 2021-08-27 | BIODEGRADABLE POLYMER DISPERSION, COMPOSITION COMPRISING THE SAME AND SKIN ENHANCEMENT SYSTEM |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230149288A1 (en) |
EP (1) | EP4122442A4 (en) |
CN (1) | CN115427012B (en) |
BR (1) | BR112022020991A2 (en) |
WO (1) | WO2022045823A1 (en) |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100360827B1 (en) * | 1999-08-14 | 2002-11-18 | 주식회사 삼양사 | Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
KR100416242B1 (en) * | 1999-12-22 | 2004-01-31 | 주식회사 삼양사 | Liquid composition of biodegradable block copolymer for drug delivery and process for the preparation thereof |
KR100446101B1 (en) * | 2000-12-07 | 2004-08-30 | 주식회사 삼양사 | Sustained delivery composition for poorly water soluble drugs |
US20040185101A1 (en) * | 2001-03-27 | 2004-09-23 | Macromed, Incorporated. | Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof |
CN1283692C (en) * | 2002-07-12 | 2006-11-08 | 天津大学 | Preparation method of polyethylene-b-polylactic acid amphiphilic diblock copolymer |
CN101283966A (en) * | 2008-06-05 | 2008-10-15 | 复旦大学 | A kind of biodegradable hydrogel controlled release preparation and its preparation method and application |
KR101014652B1 (en) * | 2008-08-01 | 2011-02-16 | (주)더페이스샵 | Cosmetic composition for washing |
CN101766584B (en) * | 2008-12-30 | 2013-03-06 | 华东理工大学 | Long-circulating degradable polymer nano microcapsule synergistically modified by polyethylene glycol/water-soluble chitosan and preparation method thereof |
CN101812227B (en) * | 2010-02-08 | 2012-01-25 | 中国科学院长春应用化学研究所 | Micelle based on non-linear polyethylene glycol-polylactic acid block copolymer and preparation method thereof |
US8889193B2 (en) * | 2010-02-25 | 2014-11-18 | The Johns Hopkins University | Sustained delivery of therapeutic agents to an eye compartment |
KR101306765B1 (en) * | 2011-02-28 | 2013-09-10 | 부산대학교병원 | drug-incorporated nanoparticles of block copolymer composed of hyaluronic acid and poly(DL-lactide-co-glycolide) |
CN102304193A (en) * | 2011-09-29 | 2012-01-04 | 胡如桂 | Preparation method and application of oligomeric hyaluronic acid |
US9987367B2 (en) * | 2012-09-06 | 2018-06-05 | Nanyang Technological University | Hyaluronic acid-based drug delivery systems |
WO2015018461A1 (en) * | 2013-08-09 | 2015-02-12 | Genbiotech | Therapeutic compositions comprising hyaluronic acid |
CN104056275B (en) * | 2014-05-30 | 2017-09-19 | 中国药科大学 | Synthesis of multifunctional active targeting hyaluronic acid-polylactic acid carrier and preparation method of anti-tumor drug micelles |
KR101752286B1 (en) * | 2014-10-31 | 2017-06-30 | (주)프로스테믹스 | Apparatus for skin care and uses thereof |
RU2721558C2 (en) * | 2015-09-15 | 2020-05-20 | Самьянг Байофармасьютикалз Корпорейшн | Pharmaceutical composition containing an anionic drug, and a method for production thereof |
KR102394532B1 (en) * | 2016-06-30 | 2022-05-06 | (주)아모레퍼시픽 | Cosmetic composition containing hyaluronic acids having different molecular weight |
CN108245483A (en) * | 2016-12-28 | 2018-07-06 | 中国人民解放军第二军医大学 | A kind of polymer nano micelle system for containing insoluble anti-tumor medicament |
KR101915381B1 (en) * | 2017-02-10 | 2018-11-05 | 광운대학교 산학협력단 | Plasma Skincare Device Having a Close Contact to Skin |
KR102378824B1 (en) * | 2018-07-13 | 2022-03-25 | 주식회사 삼양홀딩스 | Biodegradable polymeric thread filler for promoting the formation of collagen in skin and method for preparing the same |
KR102152270B1 (en) | 2018-10-19 | 2020-09-04 | 주식회사 레모넥스 | Bioactive substance deleviry carrier |
CA3119739A1 (en) * | 2018-11-15 | 2020-05-22 | Graybug Vision, Inc. | Improved aggregated microparticles |
CN110051587A (en) * | 2019-05-04 | 2019-07-26 | 广州市爱百伊生物技术有限公司 | A kind of preparation method and application of the anti-apolexis composition containing a variety of sodium hyaluronates |
CN111150883A (en) * | 2020-01-14 | 2020-05-15 | 北京四环制药有限公司 | Biodegradable injection filler, preparation method and application thereof |
-
2021
- 2021-08-27 CN CN202180026768.4A patent/CN115427012B/en active Active
- 2021-08-27 EP EP21862119.1A patent/EP4122442A4/en active Pending
- 2021-08-27 BR BR112022020991A patent/BR112022020991A2/en unknown
- 2021-08-27 WO PCT/KR2021/011507 patent/WO2022045823A1/en unknown
- 2021-08-27 US US17/996,781 patent/US20230149288A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4122442A1 (en) | 2023-01-25 |
WO2022045823A1 (en) | 2022-03-03 |
US20230149288A1 (en) | 2023-05-18 |
CN115427012A (en) | 2022-12-02 |
CN115427012B (en) | 2024-07-02 |
EP4122442A4 (en) | 2024-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022011708A2 (en) | TRANSPARENT COMPOSITION WITH SOLUBLE ACTIVE PRINCIPLE FOR HAIR LEATHER HEALTH | |
BR112021022692A2 (en) | Formulation containing cannabinoid in microparticles, method for preparing a formulation containing cannabinoid in microparticles, and method for treating an individual | |
BR112021012635A2 (en) | 3-Carbonylamino-5-cyclopentyl-1fi-pyrazole compounds having inhibitory activity on cdk2 | |
BRPI0908216A2 (en) | hair care compositions comprising sucrose polyesters | |
BR112015023409A2 (en) | pharmaceutical compositions | |
MX387712B (en) | COMPOSITION AND EQUIPMENT FOR INHIBITING PATHOGENETIC MICROBIAL INFECTION AND METHODS FOR USING THE SAME. | |
BR112012014190B8 (en) | pharmaceutical composition for the treatment of dry eye syndrome | |
BR112023026976A2 (en) | NLRP3 INFLAMASOME INHIBITORS | |
BR112022015536A2 (en) | FORMULATION FOR A PRE-TEXTURE AGENT, FORMULATION FOR AN EMBOSSING AGENT, AND FORMULATION FOR A PHOTORESISTANT Etching FORMULATION | |
BR112014018421A8 (en) | ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA AND/OR 15-HETRE AND METHODS OF USE THEREOF | |
BR112022026699A2 (en) | FRAGRANCE RELEASE MECHANISM, METHOD AND USES | |
BR112022020991A2 (en) | BIODEGRADABLE POLYMER DISPERSION, COMPOSITION COMPRISING THE SAME AND SKIN ENHANCEMENT SYSTEM | |
BR112022021454A2 (en) | NITRIC OXIDE OR NITRIC OXIDE-RELEASING COMPOSITIONS FOR USE IN THE TREATMENT OF SARS-COV AND SARS-COV-2 | |
CR20170142A (en) | ABUSE RESISTANT PHARMACEUTICAL COMPOSITIONS | |
BR112012024887A2 (en) | chitosan granules, filler, process for preparing chitosan granules, injection kit and disposal | |
BR112015022385A2 (en) | drug for a respiratory disease | |
MX2020011855A (en) | AZABENCIMIDAZOLE COMPOUNDS AND PHARMACEUTICAL PRODUCTS. | |
MA20150235A1 (en) | Use of a composition based on marine microalgae extracts for the treatment of acne | |
BRPI0906874A2 (en) | method for stabilization of s-nitrosoglutathione and composition prepared therefrom | |
BR112015023205A2 (en) | compositions and methods for live attenuated alphavirus formulations | |
CN104434799A (en) | Polyhexamethylene guanidine spray and preparation method thereof | |
BR112022026558A2 (en) | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION TO PREVENT OR TREAT RESISTANT CANCER COMPRISING THE SAME | |
BR112018072298A2 (en) | treatment of Zika virus infections using alpha-glucosidase inhibitors | |
BR112013010714A2 (en) | PHARMACEUTICAL COMPOSITION AND USE OF AN ANTIBIOTIC COMPOUND | |
EA201890703A1 (en) | COLLOID PARTICLES INTENDED FOR USE IN MEDICINE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |